[A case of Legionella pneumonia with multiple organ failure]

Jiali Li1, Rui Wen1, Hong Deng1

  • 1Department of Nephrology, Changsha Central Hospital, Changsha 410018, China.

Insights

Legionella pneumonia (LP) is a rare infection often misdiagnosed as community-acquired pneumonia (CAP). Prompt diagnosis and treatment with antibiotics like macrolides and quinolones, alongside supportive care, are crucial for patient recovery.

Area of Science:

  • Infectious Diseases
  • Internal Medicine
  • Critical Care Medicine

Background:

  • Legionella pneumonia (LP) is a rare but severe systemic infectious disease.
  • LP often presents with atypical symptoms, leading to frequent misdiagnosis as community-acquired pneumonia (CAP).

Observation:

  • A middle-aged male patient initially diagnosed with CAP presented with fever and dyspnea.
  • The patient developed severe complications including rhabdomyolysis, acute liver and renal failure, and neurological impairment.
  • Diagnosis of LP with multiple organ failure was confirmed via a positive Legionella antibody test.

Findings:

  • Initial CAP treatment was ineffective.
  • The patient recovered following treatment with moxifloxacin and azithromycin (macrolide and quinolone antibiotics) combined with continuous renal replacement therapy.
  • Successful management highlights the importance of considering LP in refractory CAP cases.

Implications:

  • Clinicians should maintain a high index of suspicion for Legionella pneumonia in patients diagnosed with CAP who do not respond to initial treatment.
  • Early and accurate diagnosis, coupled with appropriate antibiotic therapy (macrolides, quinolones) and comprehensive supportive care, can lead to favorable outcomes in severe LP cases.
  • This case underscores the critical need for awareness and timely intervention in managing this potentially fatal infection.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
2
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K